SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $31,965 | -53.7% | 10,180 | -27.2% | 0.04% | -56.0% |
| Q3 2022 | $69,000 | -5.5% | 13,980 | -21.4% | 0.08% | +2.4% |
| Q2 2022 | $73,000 | -62.2% | 17,780 | -46.7% | 0.08% | -40.6% |
| Q1 2022 | $193,000 | -22.8% | 33,380 | 0.0% | 0.14% | -23.3% |
| Q4 2021 | $250,000 | -19.9% | 33,380 | -3.5% | 0.18% | -13.9% |
| Q3 2021 | $312,000 | -25.2% | 34,580 | -0.9% | 0.21% | -33.9% |
| Q2 2021 | $417,000 | -99.9% | 34,880 | +0.9% | 0.32% | -4.5% |
| Q1 2021 | $388,679,000 | +66454.6% | 34,580 | -0.3% | 0.33% | -38.4% |
| Q4 2020 | $584,000 | +94.7% | 34,680 | +3.3% | 0.54% | +53.4% |
| Q2 2020 | $300,000 | +14.9% | 33,580 | +7.4% | 0.35% | +28.2% |
| Q4 2019 | $261,000 | -0.4% | 31,280 | +7.9% | 0.27% | -10.8% |
| Q3 2019 | $262,000 | -3.0% | 28,980 | +15.6% | 0.31% | -6.4% |
| Q2 2019 | $270,000 | +22.7% | 25,080 | +8.7% | 0.33% | +18.5% |
| Q1 2019 | $220,000 | -9.1% | 23,080 | +9.1% | 0.28% | -23.3% |
| Q4 2018 | $242,000 | -24.8% | 21,150 | +11.0% | 0.36% | -2.2% |
| Q3 2018 | $322,000 | – | 19,050 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |